Steff Lewis

ORCID: 0000-0003-1210-2314 · 2 papers in corpus · active 2012-2016

Study types

  • article 2

Condition tags

  • chronic_pelvic_pain 2
article 2016
·doi:10.1371/journal.pone.0153037

Chronic pelvic pain (CPP) affects 2.1-24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial …

article 2012
·doi:10.1136/bmjopen-2012-001297

INTRODUCTION: Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescri…